Cohere Health to Further Reduce Administrative Burden for Providers via Epic’s Payer Platform by Seini Moimoi | Apr 3, 2024 | Portfolio News
Mirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution) Receives Positive Reimbursement Recommendation by Canada’s CADTH for Patients with Cholestatic Pruritus in Alagille Syndrome by Seini Moimoi | Apr 2, 2024 | Portfolio News
Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis by Seini Moimoi | Mar 13, 2024 | Portfolio News
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing by Seini Moimoi | Mar 13, 2024 | Portfolio News
CuraSen Therapeutics Announces Oral Presentation of Additional Positive Phase 2a Data with CST-2032/CST-107 in Patients with Alzheimer’s or Parkinson’s Disease at AD/PD™ 2024 International Conference by Seini Moimoi | Mar 7, 2024 | Portfolio News
